13 Jul 2021
XVIVO presents interim report January-June 2021
Second quarter 2021 (Apr 1 – Jun 30)• Net sales amounted to SEK 59.3 million (30.4), corresponding to…
Read moreNews Tag: English
08 Jul 2021
XVIVO to start their digital transformation journey together with UMC Groningen to enable an increase in successful transplants
XVIVO and the University Medical Center Groningen (UMCG) have agreed to jointly carry out a pilot-project in advanced analytics using liver perfusion data from XVIVO’s machine for liver perfusion, Liver Assist. The project, named XCEPT, aims to extract data from the perfusion to enable advanced analysis prior to transplantation. The analysis will help the team of surgeons to make a more data-driven decision and increase the number of successful liver transplants.
Read more 30 Jun 2021
Change in number of shares and votes in XVIVO Perfusion
The number of shares and votes in XVIVO Perfusion AB (publ) has during June 2021 increased by 33,261…
Read more 28 Jun 2021
Conference call on Interim Report
Invitation to attend XVIVO’s conference call regarding the presentation of the interim report April – June 2021. The presentation will be held in English
Read more 28 May 2021
The National Institute for Health and Care Excellence (NICE) Gives Support for EVLP
The National Institute for Health and Care Excellence (NICE) has issued interventional procedure guidance recommending the use of…
Read more